GCA
Gideon Capital Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-8,416
| Closed | -$677K | – | 258 |
|
|
2019
Q3 | $677K | Buy |
+8,416
| New | +$677K | 0.22% | 151 |
|
|
2018
Q4 | – | Sell |
-6,404
| Closed | -$560K | – | 362 |
|
|
2018
Q3 | $560K | Buy |
6,404
+2,814
| +78% | +$246K | 0.26% | 121 |
|
|
2018
Q2 | $354K | Sell |
3,590
-3,395
| -49% | -$335K | 0.18% | 220 |
|
|
2018
Q1 | $832K | Buy |
+6,985
| New | +$832K | 0.52% | 31 |
|